PT - JOURNAL ARTICLE ED - , TI - Correction: Novel oncolytic adenovirus expressing enhanced cross-hybrid IgGA Fc PD-L1 inhibitor activates multiple immune effector populations leading to enhanced tumor killing in vitro, in vivo and with patient-derived tumor organoids AID - 10.1136/jitc-2021-003000corr1 DP - 2021 Sep 01 TA - Journal for ImmunoTherapy of Cancer PG - 1--1 VI - 9 IP - 9 4099 - http://jitc.bmj.com/content/9/9/1.3.short 4100 - http://jitc.bmj.com/content/9/9/1.3.full SO - J Immunother Cancer2021 Sep 01; 9